CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Solar Therapeutics
Solar Therapeutics logo

Solar Therapeutics

Solar Cannabis Co.: America's first energy-independent, eco-friendly cannabis cultivator and premier supplier.

Somerset, MA, US🇺🇸
Founded
2017
Overview
Compare
Fundraising
Employees
Library

Solar Cannabis Co. is America's first energy-independent cannabis cultivation and retail facility based in Somerset, MA. The company focuses on sustainable cannabis production through innovative green infrastructure and microgrid assets, significantly reducing carbon emissions. Solar is committed to implementing eco-friendly practices to cultivate a better future through cannabis, serving as Massachusetts' premier adult-use marijuana supplier.

Solar offers a range of cannabis products, including vape carts made with glass and ceramic for a cleaner experience, and artisanal edibles under the brand "byky." These edibles combine nutrient-rich, plant-based superfoods with pure CO2 extracted cannabis. The company's commitment to sustainability and product quality positions it as a leader in the evolving cannabis industry, aiming to elevate body, mind, and soul through its offerings.

Solar Therapeutics - Similar Companies

Ember Gardens logo

Ember Gardens

embergardens.com

Greencare Collective logo

Greencare Collective

SunMed Growers logo

SunMed Growers

sunmedgrowers.com

Triple M logo

Solar Therapeutics - Quick Facts

Who are Solar Therapeutics' competitors?

Companies similar to Solar Therapeutics include Ember Gardens, Greencare Collective, SunMed Growers and Triple M.

When was Solar Therapeutics founded?

Solar Therapeutics was founded in 2017.

Where is Solar Therapeutics' headquarters located?

Solar Therapeutics' headquarters is located in Somerset, MA, US.

When was Solar Therapeutics' last funding round?

Solar Therapeutics' most recent funding round was for $5M (USD) in June 2022.

How much disclosed funding has Solar Therapeutics raised?

Solar Therapeutics - Classification

Ownership
  • Private
Technology
  • Agriculture
Geographic Exposure
  • United States

As of Jun 7, 2022, Solar Therapeutics has disclosed funding of $5M (USD). Undisclosed round amounts are excluded.

How many employees does Solar Therapeutics have?

Solar Therapeutics has 175 employees as of Feb 4, 2024.

Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Cannabis
  • Retail
Tags
  • eCommerce
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance

Triple M

mm-ma.org

Solstice logo

Solstice

Solaris Farms logo

Solaris Farms

solarisfarms.org

Sonder logo

Sonder

sondertime.com

Root & Bloom logo

Root & Bloom

The Pass logo

The Pass

thepass.co

Keystone Bluff logo

Keystone Bluff

Green Dot Labs logo

Green Dot Labs

greendotlabs.com

Theory Wellness logo

Theory Wellness

theorywellness.org

Milkmen Cannabis logo

Milkmen Cannabis

253 Organic logo

253 Organic

253farmacy.com

Waveseer logo

Waveseer

waveseerinc.com